We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Denny Jacob International stocks trading in New York closed mostly lower on Monday. The S&P/BNY Mellon index of American depositary receipts edged up 0.2% to 152.20. The European index...
By Colin Kellaher U.S.-listed shares of Nanobiotix surged in premarket trading Monday after the clinical-stage biotechnology company said it inked a licensing, co-development and commercialization...
Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – la « Société ») est une société française de biotechnologie en phase de développement clinique avancé, pionnière des approches...
Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - la « Société ») est une société française de biotechnologie en phase de développement clinique avancé, pionnière des approches...
Data presented at the 2022 Annual Meeting of the American Association of Cancer Research New data from an open-label preclinical study in mice evaluating the changes in immune-related genes...
Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - la « Société ») est une société française de biotechnologie en phase de développement clinique avancé, pionnière des approches...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -4.59459459459 | 3.7 | 3.93 | 3.5 | 38520 | 3.71469839 | DE |
4 | -0.938 | -20.993733214 | 4.468 | 4.47 | 3.5 | 59023 | 3.94436584 | DE |
12 | -1.52 | -30.099009901 | 5.05 | 5.13 | 3.5 | 49847 | 4.34476381 | DE |
26 | -3.02 | -46.106870229 | 6.55 | 6.6 | 3.5 | 68276 | 4.75519019 | DE |
52 | -2.07 | -36.9642857143 | 5.6 | 7.93 | 3.5 | 71102 | 5.49597631 | DE |
156 | -4.715 | -57.1861734384 | 8.245 | 10.4 | 1.612 | 118315 | 5.85465236 | DE |
260 | -3.17 | -47.3134328358 | 6.7 | 17.34 | 1.612 | 116084 | 7.29381646 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions